Covid-19 Vaccine
CEPI funds BioNTech’s mRNA-based mpox vaccine trial with $90 million
BioNTech, the German biotech renowned for its groundbreaking mRNA COVID-19 vaccine, is embarking on clinical trials for an mRNA vaccine ...
Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna
In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...
COVID-19 Vaccine Makers Prepare for Private-Market Launches Amid Evolving Variants
Following a decline in demand for COVID-19 vaccines, prominent biopharmaceutical companies are gearing up for private-market launches this upcoming fall. ...
Moderna finds promise in the private COVID vaccination market and the debut of RSV as sales plummet
Source – Fiercepharma As Moderna continues its operations beyond the pandemic, the biotech firm has increased its revenue projection for ...
Moderna Files Two New Patent Lawsuits Against mRNA Competitors Pfizer and BioNTech
In the ongoing patent disputes surrounding COVID-19 vaccines, Moderna has expanded its legal battle against Pfizer and BioNTech by filing ...
Novavax’s Covid vaccine receives a unanimous EU approval
Source – Novavax Novavax received full Marketing Authorization (MA) from the European Commission for its COVID-19 vaccine, Nuvaxovid (NVX-CoV2373). This ...
For its updated Covid-19 vaccine, Moderna submits a regulatory application to the European Medicines Agency
Source – Moderna On July 3, 2023 Moderna announced the submission of a regulatory application to the European Medicines Agency ...
